← Browse by Condition
Medical Condition

flt3 tkd mutation

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06022003 Phase 2
Recruiting

Study Investigating the Efficacy and Safety of the Addition of Oral-azacitidine to Salvage Treatment by Gilteritinib in Subjects ≥18 Years of Age With Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia

Enrollment
33 pts
Location
France
Sponsor
French Innovative Leukemia Org...
View Trial →